Tech Investors

RxCelerate

RxCelerate is a tech investor that backs technology-driven innovators.

Venture Investor Overview

Venture Investor
RxCelerate
Status
InActive
Investor Type
Other
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical

Contact Information

Contact
Jill Reckless
Title
Chief Executive Officer
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Phone
Undisclosed
Email Address

Background Information

Overview
RxCelerate is the realisation of the vision of our Founders, David Grainger & Jill Reckless, to make world-class drug discovery and development capabilities available to anyone with a good idea. David and Jill have worked together for almost 25 years, since Jill joined the Cambridge University laboratory David was running together with Professor Jim Metcalfe.
Profile
RxCelerate LinkedIn Company Profile
Social Media
RxCelerate Company Twitter Account
Company News
RxCelerate News
Facebook
RxCelerate on Facebook
YouTube
RxCelerate on YouTube
Last Transaction
9/22/2022

Transaction History

Our records indicate that RxCelerate invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
9/22/2022
$132,000,000
7/22/2021
$35,000,000

 


Investor Contacts

Title
Name
Email & Social
Chief Executive Officer
Jill Reckless
  Jill Reckless LinkedIn Profile  Jill Reckless Twitter Account  Jill Reckless News  Jill Reckless on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

RxCelerate has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more tech investors:

Rush University Medical Center | s20 Capital

 

Share this article

 


About Our Tech Investor Database

This tech investor profile is powered by VentureDeal.com, a leading provider of tech investor transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary